CARA
Cara Therapeutics Inc
Price:  
0.24 
USD
Volume:  
1,364,755.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CARA EV/EBITDA

-11492.3%
Upside

As of 2024-06-19, the EV/EBITDA ratio of Cara Therapeutics Inc (CARA) is 0.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CARA's latest enterprise value is -28.76 mil USD. CARA's TTM EBITDA according to its financial statements is -123.52 mil USD. Dividing these 2 quantities gives us the above CARA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 9.9x - 18.2x 14.4x
Forward P/E multiples 18.6x - 20.3x 20.0x
Fair Price (30.00) - (29.25) (27.64)
Upside -12467.6% - -12156.1% -11492.3%
0.24 USD
Stock Price
(27.64) USD
Fair Price

CARA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-18 0.23
2024-06-17 0.23
2024-06-14 0.17
2024-06-13 0.11
2024-06-12 -0.03
2024-06-11 -0.02
2024-06-10 -0.03
2024-06-07 0.00
2024-06-06 -0.01
2024-06-05 -0.04
2024-06-04 -0.02
2024-06-03 -0.03
2024-05-31 -0.01
2024-05-30 0.02
2024-05-29 0.01
2024-05-28 -0.03
2024-05-24 -0.03
2024-05-23 -0.07
2024-05-22 -0.09
2024-05-21 -0.08
2024-05-20 -0.08
2024-05-17 -0.08
2024-05-16 -0.11
2024-05-15 -0.08
2024-05-14 -0.06
2024-05-13 -0.08
2024-05-10 -0.06
2024-05-09 -0.08
2024-05-08 -0.07
2024-05-07 -0.10
2024-05-06 -0.10
2024-05-03 -0.09
2024-05-02 -0.09
2024-05-01 -0.08
2024-04-30 -0.08
2024-04-29 -0.08
2024-04-26 -0.04
2024-04-25 -0.05
2024-04-24 -0.03
2024-04-23 -0.05
2024-04-22 -0.06
2024-04-19 -0.02
2024-04-18 -0.04
2024-04-17 -0.06
2024-04-16 -0.05
2024-04-15 -0.05
2024-04-12 -0.08
2024-04-11 -0.11
2024-04-10 -0.11
2024-04-09 -0.13